מאמרים עם הרשאות לגישה ציבורית - Oskar Hanssonלמידע נוסף
לא זמינים באתר כלשהו: 27
Biomarkers for neurodegenerative diseases
O Hansson
Nature medicine 27 (6), 954-963, 2021
הרשאות: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
CSF and blood biomarkers for Parkinson's disease
L Parnetti, L Gaetani, P Eusebi, S Paciotti, O Hansson, O El-Agnaf, ...
The Lancet Neurology 18 (6), 573-586, 2019
הרשאות: Government of Italy
CSF biomarkers predict a more malignant outcome in Alzheimer disease
AK Wallin, K Blennow, H Zetterberg, E Londos, L Minthon, O Hansson
Neurology 74 (19), 1531-1537, 2010
הרשאות: Swedish Research Council
Apathy and anxiety are early markers of Alzheimer's disease
M Johansson, E Stomrud, O Lindberg, E Westman, PM Johansson, ...
Neurobiology of aging 85, 74-82, 2020
הרשאות: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
N Mattsson, A Lönneborg, M Boccardi, K Blennow, O Hansson, ...
Neurobiology of aging 52, 196-213, 2017
הרשאות: Swiss National Science Foundation, Swedish Research Council, European Commission
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
M Holtta, L Minthon, O Hansson, J Holmén-Larsson, I Pike, M Ward, ...
Journal of proteome research 14 (2), 654-663, 2015
הרשאות: Swedish Research Council
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease
J Daborg, U Andreasson, M Pekna, R Lautner, E Hanse, L Minthon, ...
Journal of Neural Transmission 119, 789-797, 2012
הרשאות: Swedish Research Council
Low IL‐8 is associated with anxiety in suicidal patients: genetic variation and decreased protein levels
S Janelidze, P Suchankova, A Ekman, S Erhardt, C Sellgren, ...
Acta Psychiatrica Scandinavica 131 (4), 269-278, 2015
הרשאות: Swedish Research Council
Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease
A Leuzy, NC Cullen, N Mattsson-Carlgren, O Hansson
Current opinion in neurology 34 (2), 266-274, 2021
הרשאות: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
Association of enlarged perivascular spaces and measures of small vessel and Alzheimer disease
EC Gertje, D van Westen, C Panizo, N Mattsson-Carlgren, O Hansson
Neurology 96 (2), e193-e202, 2021
הרשאות: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters
S Janelidze, F Ventorp, S Erhardt, O Hansson, L Minthon, J Flax, ...
Psychoneuroendocrinology 38 (6), 853-862, 2013
הרשאות: Swedish Research Council
Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease
G Brinkmalm, A Brinkmalm, P Bourgeois, R Persson, O Hansson, ...
Brain research 1513, 117-126, 2013
הרשאות: Swedish Research Council
Striatal changes in Parkinson disease: An investigation of morphology, functional connectivity and their relationship to clinical symptoms
C Owens-Walton, D Jakabek, X Li, FA Wilkes, M Walterfang, D Velakoulis, ...
Psychiatry Research: Neuroimaging 275, 5-13, 2018
הרשאות: National Health and Medical Research Council, Australia, Swedish Research …
Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild …
K Buerger, O Uspenskaya, O Hartmann, O Hansson, L Minthon, ...
The Journal of clinical psychiatry 71 (4), 15017, 2010
הרשאות: Science Foundation Ireland
Beta-blocker therapy and risk of vascular dementia: A population-based prospective study
H Holm, F Ricci, G Di Martino, E Bachus, ED Nilsson, P Ballerini, ...
Vascular pharmacology 125, 106649, 2020
הרשאות: Knut and Alice Wallenberg Foundation
Plasma NT1 tau is a specific and early marker of Alzheimer's disease
D Mengel, S Janelidze, RJ Glynn, W Liu, O Hansson, DM Walsh
Annals of Neurology 88 (5), 878-892, 2020
הרשאות: German Research Foundation
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
S Hall, S Janelidze, H Zetterberg, B Brix, N Mattsson, Y Surova, ...
Movement Disorders 35 (3), 513-518, 2020
הרשאות: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
The interactive effect of demographic and clinical factors on hippocampal volume: a multicohort study on 1958 cognitively normal individuals
D Ferreira, O Hansson, J Barroso, Y Molina, A Machado, ...
Hippocampus 27 (6), 653-667, 2017
הרשאות: US National Institutes of Health, National Health and Medical Research …
Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases
M Nutu, P Bourgeois, H Zetterberg, E Portelius, U Andreasson, S Parent, ...
Neuromolecular medicine 15, 169-179, 2013
הרשאות: Swedish Research Council
Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson's disease
C Owens-Walton, D Jakabek, BD Power, M Walterfang, S Hall, ...
Psychiatry Research: Neuroimaging 312, 111273, 2021
הרשאות: Knut and Alice Wallenberg Foundation, Marianne and Marcus Wallenberg …
המידע על הפרסום ועל הגורמים המממנים נקבע באופן אוטומטי על ידי תוכנת מחשב